Top compounds associated with response to TCF25


Feature Type Standardized
Nominal ANOVA
mRNA tivozanib CTRPv2 pan-cancer AAC 0.09 0.01
mRNA bafilomycin A1 CTRPv2 pan-cancer AAC 0.34 0.01
mRNA JW-480 CTRPv2 pan-cancer AAC -0.091 0.02
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.02
mRNA navitoclax:birinapant (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA MLN2238 CTRPv2 pan-cancer AAC -0.082 0.02
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.086 0.02
mRNA KPT185 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA BRD-K71781559 CTRPv2 pan-cancer AAC -0.09 0.02
mRNA RITA CTRPv2 pan-cancer AAC 0.082 0.02
Download CSV